TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
TCL Archive FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug. June 9, 2006
